Sign In
Buy AXSM
$233.49
+11.33 (+5.10%)
At Close: Jun 03, 2026
3 Biotech Stocks That Are Too Cheap to Ignore
06:02am, Thursday, 02'nd Sep 2021
You'll definitely want to check out these biotech bargains.
Here's Why Axsome Therapeutics Stock Is Surging Today
02:42pm, Wednesday, 01'st Sep 2021
The company still doesn't have much to say about the FDA and its experimental new anti-depression drug.
Which Biotech Stock Will Shock the Market in 2022?
10:40am, Friday, 27'th Aug 2021
Over the last few years, three tiny biotechs emerged out of nowhere to give amazing returns to early investors. Which biotech might pull off a similar feat in 2022?
Axsome's (AXSM) Stock Up Despite FDA Delay on Depression Drug
12:59pm, Tuesday, 24'th Aug 2021
FDA delays decision on Axsome Therapeutics' (AXSM) new drug application for AXS-05, a potential treatment for major depressive disorder.
Why Axsome Therapeutics Stock Is Jumping Today
12:15pm, Monday, 23'rd Aug 2021
Investors are happy that the FDA didn't ask for more information to supplement Axsome's regulatory filing for AXS-05.
Axsome Therapeutics Shares Increase Over 20% Pre-Market: Why It Happened
07:53am, Monday, 23'rd Aug 2021
The shares of Axsome Therapeutics Inc (NASDAQ: AXSM) increased by over 20% pre-market. This is why it happened.
Axsome Therapeutics Provides Update on the New Drug Application for AXS-05 for the Treatment of Major Depressive Disorder
06:00am, Monday, 23'rd Aug 2021
NEW YORK, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorder
Is the Options Market Predicting a Spike in Axsome (AXSM) Stock?
11:25am, Friday, 20'th Aug 2021
Investors need to pay close attention to Axsome (AXSM) stock based on the movements in the options market lately.
Could Biogen Acquire Axsome Therapeutics?
06:01am, Friday, 20'th Aug 2021
Here are three reasons why a buyout just might happen.
BioXcel: Recent Selloff Offers A Very Good Opportunity To Entry At A Discount Price
02:32pm, Wednesday, 18'th Aug 2021
BioXcel: Recent Selloff Offers A Very Good Opportunity To Entry At A Discount Price
3 Beaten Down Stocks that Could be Ready to Bounce
07:14am, Tuesday, 17'th Aug 2021
Photo credit sergeitokmakov @ Pixabay Trading against the trend can be a very difficult way to generate returns in the market, yet there usually comes a time when a stock in a downtrend simply runs ou
2 Beaten-Down Biotech Stocks: Are They Bargains Now?
06:31am, Tuesday, 17'th Aug 2021
These drugmakers delivered some upsetting news, but was it really so bad?
Los Angeles, California--(Newsfile Corp. - August 16, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ax
Axsome: Is The Pullback A Buying Opportunity?
08:00am, Sunday, 15'th Aug 2021
Axsome is down due to two adverse events. The first, rescinding of the BTD for AXS-12, is a non-event.
Why Shares of Axsome Therapeutics Are Down Friday
03:29pm, Friday, 13'th Aug 2021
The biotech stock has lost half of its value over the past week.
